Researchers from the USA have developed a model showing of how highly concentrated antibody solutions are separated into different phases, like water and oil. Such separation may reduce the stability and the shelf life of some drugs, accordingly.

American startup Ventrix has developed and successfully tested VentriGel hydrogel-based remedy for repairing heart damage.

The vaccine is intended for inhalation and works in the lungs causing the body to produce the immune response directly in the lung cells. This approach should allow to use the vaccine in all groups of patients, in contrast to BCG, which has several limitations.

Researchers from Google have reported that their AI can detect and identify 26 skin conditions (as much as a certified American dermatologist determines).

The university has opened a Centre for the study of psychedelics as medications for the treatment of neurological diseases. It was sponsored by Steven and Alexandra Cohen Foundation and four benefactors who raised about $ 17 million.

"Innovative" and "provocative" therapies with mesenchymal stem cells in case of progressive multiple sclerosis have shown good results.

Scientists from Stanford University School of Medicine have reported the success of the world's first complete digital randomized clinical trial. A document showing the results of the work was published in The Lancet Digital Health.

Swedish medicines manufacturer Orexo, best known for its medicines for opioid addiction, has licensed an innovative digital therapy for alcohol addiction.

A blood test for detection of inflammation can foresee an individual risk of developing heart and vascular diseases or early death 40 years before real problems arise. The authors of the development are the scientists of Sloan Kettering Cancer Center.